You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

irinotecan

Showing 26 - 50 of 1,952
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Objective Response, Overall Survival Trial in Beijing (VIA combination treatment)

Completed
  • Objective Response
  • Overall Survival
  • VIA combination treatment
  • Beijing, China
    Peking University People's Hospital
Dec 9, 2022

Colorectal Cancer Metastatic Trial in Guangzhou (Dexamethasone, Anisodamine, Oxaliplatin)

Recruiting
  • Colorectal Cancer Metastatic
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 3, 2023

Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma, Refractory Bile Duct Carcinoma Trial in Rochester (Irinotecan,

Active, not recruiting
Has Results
  • Advanced Bile Duct Carcinoma
  • +17 more
  • Irinotecan
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 5, 2023

Malignant Solid Tumor Trial in United States (drug, other, procedure)

Active, not recruiting
  • Malignant Solid Neoplasm
  • Baltimore, Maryland
  • +5 more
Nov 8, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Completed
Has Results
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +8 more
  • Bevacizumab
  • Irinotecan Sucrosofate
  • Chicago, Illinois
    Northwestern University
Dec 21, 2022

Metastatic Pancreatic Cancer Trial in Singapore (Low Dose OXIRI (LD-OXIRI))

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Low Dose OXIRI (LD-OXIRI)
  • Singapore, Singapore
    National Cancer Centre, Singapore
Jun 29, 2023

Ewing Sarcoma Trial in Beijing (Vincristine, Temozolomide)

Recruiting
  • Ewing Sarcoma
  • Beijing, Beijing, China
    Peking University People's Hospital
Oct 31, 2022

Relapsed Neuroblastoma, Refractory Neuroblastoma Trial (Natural Killer Cells, Temozolomide, Irinotecan)

Recruiting
  • Relapsed Neuroblastoma
  • Refractory Neuroblastoma
  • Natural Killer Cells
  • +4 more
  • Columbus, Ohio
    Nationwide Children's Hospital
Oct 26, 2022

Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal

Recruiting
  • Colorectal Adenocarcinoma
  • +13 more
  • Nanoliposomal Irinotecan
  • Trifluridine and Tipiracil Hydrochloride
  • Atlanta, Georgia
  • +2 more
Jan 6, 2023

Metastatic Colorectal Cancer Trial in Toronto (Hydroxychloroquine, Irinotecan, Leucovorin)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 24, 2023

Desmoplastic Small Round Cell Tumor, Rhabdomyosarcoma Trial in New York (Prexasertib, Irinotecan)

Active, not recruiting
  • Desmoplastic Small Round Cell Tumor
  • Rhabdomyosarcoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 3, 2022

SBX-01-101: A Stool Collection Study in Colorectal Cancer

Recruiting
  • Colorectal Cancer
  • Stool Collection and Survey Completion
  • Woburn, Massachusetts
    Sanguine Biosciences, Inc.
Apr 18, 2023

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Active, not recruiting
  • Recurrent Anaplastic Astrocytoma
  • +6 more
  • Carboxylesterase-expressing Allogeneic Neural Stem Cells
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Cholangiocarcinoma Trial in Düsseldorf (Combination of Lonsurf® and Irinotecan)

Recruiting
  • Cholangiocarcinoma
  • Combination of Lonsurf® and Irinotecan
  • Düsseldorf, NRW, Germany
    Klinik für Gastroenterologie, Hepatologie und Infektiologie
Dec 22, 2022

Metastatic Colorectal Cancer Trial (AUM001, Pembrolizumab, Irinotecan)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Jul 13, 2022

Rhabdomyosarcoma, Child Trial (Doxorubicin Hydrochloride Liposome+Irinotecan, Temozolomide+Irinotecan+Vincristine)

Not yet recruiting
  • Rhabdomyosarcoma, Child
  • (no location specified)
Jul 13, 2022

Metastatic Cancer, Unspecified Adult Solid Tumor Trial in Los Angeles (PARP inhibitor BMN-673, temozolomide, irinotecan HCl)

Completed
  • Metastatic Cancer
  • Unspecified Adult Solid Tumor
  • PARP inhibitor BMN-673
  • +4 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Sep 22, 2022

Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8 Trial in Houston

Active, not recruiting
  • Metastatic Colorectal Carcinoma
  • +4 more
  • Cetuximab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 4, 2022

Advanced Esophageal Squamous Cell Carcinoma Trial in Beijing, Xiamen, Xinxiang (Afatinib, Irinotecan)

Recruiting
  • Advanced Esophageal Squamous Cell Carcinoma
  • Beijing, China
  • +2 more
Apr 6, 2023

Pancreatic Ductal Adenocarcinoma Trial in United States (Onvansertib, Nanoliposomal irinotecan, Leucovorin)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Phoenix, Arizona
  • +5 more
Dec 15, 2022

Rectal Cancer, Locally Advanced Trial in Tunis (Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan),

Active, not recruiting
  • Rectal Cancer
  • Locally Advanced
  • Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan)
  • Radiotherapy
  • Tunis, Tunisia
    Amel Mezlini
May 19, 2023

UGT1A1 Genotyping in Taiwanese Cancer Patients

Not yet recruiting
  • The Influence of the UGT1A1 Genotype
    • (no location specified)
    Mar 20, 2023

    Homologous Recombination Deficiency Alterations Metastatic Colorectal Cancer Trial in Shanghai (Fluzoparib, Irinotecan)

    Not yet recruiting
    • Homologous Recombination Deficiency Alterations Metastatic Colorectal Cancer
    • Shanghai, Shanghai, China
      Department of Colorectal Surgery Fudan University Shanghai Caner
    Feb 22, 2023

    Malignant Tumor, Diarrhea Trial in Guangzhou (Xiao Chai Hu Tang (XCHT), Raloxifene, FOLFIRI regimen)

    Recruiting
    • Malignant Tumor
    • Diarrhea
    • Xiao Chai Hu Tang (XCHT)
    • +2 more
    • Guangzhou, Guangdong, China
      Guangdong Provincial Hospital of Chinese Medicine
    Aug 11, 2022

    Toripalimab, Radiation Trial in Hangzhou (Toripalimab, CRT, SCRT)

    Recruiting
    • Toripalimab
    • Radiation
    • Hangzhou, Zhejiang, China
      Zhengjiang Cancer Hospital
    Dec 29, 2022